cellular pathways underlying this local regulation have remained undefined.
Ankyrin polypeptides play critical roles in ion channel and transporter targeting in excitable and nonexcitable cells. Ankyrin-R (ANK1) links membrane transporters to the cytoskeleton in erythrocytes, and human ANK1 mutations cause hereditary spherocytosis. 9 Ankyrin-B (ANK2) is critical for ion channel and transporter targeting in heart, brain, and pancreas, and ankyrin-B dysfunction has been linked with sinus node disease, atrial fibrillation, ventricular arrhythmia, and diabetes mellitus. [10] [11] [12] [13] [14] Finally, ankyrin-G (ANK3) plays central roles for ion channel targeting in neurons. 15 Although in vitro work supports an association between ankyrin-G and Na v 1.5 in heart, 16, 17 little is known about the role of this complex in vivo. Further, a link between ankyrin-G/Na v 1.5 and CaMKIIδ is undefined. Finally, the functional pathophysiological consequences for disrupting any of these putative complexes are unknown.
We report the molecular basis of a novel signaling platform in heart that couples CaMKIIδ to Na v 1.5. Our in vivo data demonstrate that ankyrin-G serves as an intercalated disc receptor for both Na v 1.5 and β IV spectrin, a molecule originally identified in brain and linked with neurological disease. 18 Mice harboring a conditional null allele for ankyrin-G in heart (cKO) are surprisingly viable, but display decreased Na v 1.5 expression, membrane localization, and I Na associated with bradycardia, conduction abnormalities, QRS prolongation, and ventricular arrhythmias in response to Na v channel antagonists. Further, ankyrin-G cKO mice show loss of β IV spectrin recruitment to the intercalated disc membrane. β IV spectrin C-terminal domain associates with CaMKIIδ, and ankyrin-G cKO mice, as well as β IV spectrin mutant mice lacking the C-terminal domain (qv 4J ), show defects in CaMKIIδ targeting and CaMKIIδ-dependent regulation of I Na,L . Finally, we report that the ankyrin-G-dependent protein platform links Na v channels with broader intercalated disc signaling/structural nodes, as in vivo ankyrin-G loss results in remodeling of plakophilin-2, a resident desmosome protein critical for intercalated disc integration with the intermediate filament-based cytoskeleton. Together, our findings identify a novel molecular platform critical for the membrane recruitment and regulation of Na v 1.5 in heart. These findings further provide new insight into the pathways underlying cardiac excitability in health and disease.
Methods Biochemistry
Immobilized glutathione-S-transferase-fusion proteins were incubated with 100 μg left ventricular heart lysate overnight in pull-down buffer at 4°C. 19 The samples were washed 3× in pull-down buffer, eluted, and proteins were separated by SDS/PAGE (sodium dodecyl sulfate/polyacrylamide gel electrophoresis). The gels were transferred to nitrocellulose and immunoblotted. Nitrocellulose blots were developed using standard protocols.
Additional Methods are found in Online Data Supplement.
Results

Generation of Mice With Cardiac-Specific Deletion of Ankyrin-G
Based on its role in assembly of excitable domains in the nervous system, 20 and in vitro links with Na v 1.5 in myocytes, 21 generated a conditional null mutant allele where exons 22 to 23 the mouse ankyrin-G gene (Ank3) is flanked by LoxP sites (Ank3 f/f ) and therefore are deleted in the presence of Cre recombinase ( Figure 1A-1C ). We selectively eliminated ankyrin-G in postnatal cardiomyocytes by using αMHC-Cre knock-in mice 22 ; homozygous conditional knockout mice are referred to as αMHC-Cre; Ank3 f/f or cKO. αMHC-Cre; Ank3 f/f wild-type (WT) age-and sex-matched littermates were used as control mice. Surprisingly, cKO mice were viable, displayed no gross differences in size, weight, feeding, and grooming, and showed no apparent deficits in motor function, unlike mice harboring selective deletion of cerebellar ankyrin-G. 20 Immunoblots from whole heart lysates showed elimination of ankyrin-G in cKO heart ( Figure 1D ). Selective loss of ankyrin-G in the heart was confirmed by immunoblot from cortex, cerebellum, skeletal muscle, and kidney of control and cKO mice where we observed no difference in ankyrin-G expression ( Figure 1E and 1F). At the level of the single ventricular myocyte, ankyrin-G is enriched at the intercalated disc along with N-cadherin ( Figure 1G ). Ankyrin-G expression at the intercalated disc (and minor population at transverse-tubule) was eliminated from cKO ventricular myocytes ( Figure 1H ).
Ankyrin-G cKO Mice Display Abnormal Na v Channel Targeting and Function
Ankyrin-G is linked with voltage-gated Na v channel function in cerebellum. 20 We, therefore, examined Na v 1.5 expression, localization, and function in ankyrin-G cKO hearts. We observed a significant decrease in Na v 1.5 expression in cKO hearts by immunoblot ( Figure 2A and 2B; P<0.05). Although primarily localized to the intercalated disc, Na v 1.5 is also found in secondary populations at the peripheral sarcolemma. 23, 24 In line with immunoblot data, Na v 1.5 expression was significantly reduced in cKO compared with WT myocytes ( Figure 2C and 2D). Moreover, consistent with the localization of ankyrin-G, we observed selective loss of Na v 1.5 from the intercalated disc in cKO myocytes ( Figure 2C -2F). Na v 1.5 immunostaining at the peripheral sarcolemma in cKO myocytes was unaffected ( Figure 2C -2F). However, we observed populations of intracellular Na v 1.5-positive puncta in ankyrin-G cKO myocytes ( Figure 2F ). This loss was specific for Na v 1.5 as expression levels of Ca v 1.2, Na/Ca exchanger 1, and ankyrin-B were unchanged between WT and cKO hearts (Online Figure I) . Consistent with these data, we observed ≈50% reduction in peak I Na in cKO myocytes compared with myocytes from WT littermates ( Figure 2G -2J). Although I Na was reduced in cKO myocytes, we observed no difference in Na v 1.5 steady-state voltage-dependent inactivation or recovery from inactivation (Online Figure II) . Finally, consistent with prior findings in Scn5a +/mice, 25 loss of I Na in cKO myocytes resulted in a significant decrease in action potential amplitude and maximum upstroke velocity (V max ; Online Figure III ). Together, these findings demonstrate an in vivo requirement of ankyrin-G for cardiac Na v 1.5 membrane expression and function.
Ankyrin-G Recruits β IV Spectrin to the Myocyte Intercalated Disc
Ankyrins partner with spectrin polypeptides to bridge membrane and cytoskeletal structures. 26 In the nervous system, although ankyrin-G and β IV spectrin are required for assembly of the axon initial segment, ankyrin-G seems to serve as the primary organizing protein. To investigate the functional relationship between ankyrin-G and β IV spectrin in heart, we Figure 2 . Ankyrin-G is required for myocyte Na v 1.5 expression and localization. A-B, Immunoblots of Na v 1.5 in wild-type (WT) and cKO heart. We observed reduced Na v 1.5 protein levels in cKO heart. In B, Na v 1.5 expression levels are normalized to GAPDH loading control (n=4/genotype; P<0.05). C-D, Na v 1.5 immunostaining (red) is significantly reduced at the intercalated disc of cKO myocytes (Bar=10 μm). Myocytes were colabeled for N-cadherin (green) and nuclei (blue DAPI). E-F, Magnified images of Na v 1.5 immunostaining of peripheral sarcolemma and intercalated disc of WT and cKO myocytes. Note in E that Na v 1.5 is localized at both intercalated disc (white arrow) and peripheral sarcolemma membrane (yellow arrows). Although disc staining is reduced in cKO myocytes, the sarcolemmal staining is unaltered (F). In cKO myocytes, we also observed intracellular Nav1.5positive puncta (blue arrows). G-H, Representative I Na traces from WT and cKO mouse myocytes. I-J, Reduced I Na current in cKO versus WT myocytes (WT, n=10; cKO, n=9; P<0.05). November 7, 2014 tested the localization of β IV spectrin in ankyrin-G cKO mice.
In WT myocytes and heart, β IV spectrin was concentrated at the intercalated disc membrane ( Figure 3 ; Online Figure  IV ). 8 However, β IV spectrin was nearly absent from the intercalated disc membrane of cKO myocytes ( Figure 3 ; Online Figure IV ). Instead, we observed populations of β IV spectrinpositive puncta near the peri-nuclear region in cKO myocytes ( Figure 3 ). Thus, ankyrin-G is required for the recruitment of β IV spectrin to the myocyte intercalated disc.
β IV Spectrin Is Not Required for Ankyrin-G or Na v 1.5 Targeting in Myocytes
We tested the converse requirement of β IV spectrin for ankyrin-G and Na v 1.5 targeting in heart. For these experiments, we used a β IV spectrin mutant mouse model (qv 4J mice) harboring a premature stop codon in the 10th spectrin repeat, resulting in a truncated polypeptide lacking ankyrin-G-binding activity (located in 15th spectrin repeat; see Figure 4A ). 18, 19 As expected, a glutathione-S-transferase-β IV spectrin fusion protein harboring the qv 4J mutation lacked binding activity for ankyrin-G and Na v 1.5 ( Figure 4B ). In contrast to findings in neurons, 27 qv 4J myocytes displayed no significant difference in ankyrin-G or Na v channel expression compared with control hearts by immunoblot ( Figure 4C and 4D). Further, we observed no difference in intercalated disc proteins N-cadherin or β-catenin in qv 4J hearts ( Figure 4C and 4D). In line with immunoblot data, we observed no difference in ankyrin-G or Na v 1.5 localization at the intercalated disc between control and qv 4J myocytes ( Figure 4E-4H ). However, consistent with the role of the β IV spectrin C-terminus in CaMKIIδ targeting, 8 qv 4J myocytes displayed a significant decrease in CaMKIIδ expression ( Figure 4C and 4D; P<0.05). In summary, our findings define a requirement of ankyrin-G for β IV spectrin targeting to the intercalated disc, whereas ankyrin-G is targeted to the disc independent of β IV spectrin-binding.
Ankyrin-G Recruits CaMKIIδ to the Myocyte Intercalated Disc
β IV spectrin, via a short C-terminal motif, associates with CaMKIIδ. 8 β IV spectrin mutant mice lacking this C-terminal motif display aberrant CaMKIIδ intercalated disc targeting. 8 Based on the loss of β IV spectrin in ankyrin-G cKO hearts (Figure 3 ), we hypothesized that ankyrin-G cKO hearts would display decreased CaMKIIδ expression and abnormal intercalated disc targeting. We observed reduced CaMKIIδ expression by immunoblot in cKO versus control hearts ( Figure 5A and 5B). In cKO heart, we observed selective loss of CaMKIIδ at the intercalated disc (location of β IV spectrin) versus other myocyte membrane populations (ie, transversetubules, Figure 5C and 5D; Online Figure V ). Thus, ankyrin-G, via β IV spectrin, controls the intracellular targeting of CaMKIIδ to the intercalated disc.
Ankyrin-G Recruits CaMKIIδ to Regulate Na v 1.5 Phosphorylation
In response to sympathetic stimulation, CaMKIIδ phosphorylates Na v 1.5 via serine 571 to regulate Na v 1.5-dependent late current (I Na,L ). 8, 28 Ankyrin-G recruits both Na v 1.5 and CaMKIIδ to the intercalated disc (Figures 2 and 5 ). In line with these data, we observed reduced Na v 1.5 serine 571 phosphorylation by both immunoblot and immunostaining in cKO myocytes compared with control cells (Online Figure VIA-VID). When corrected for peak I Na , we did not observe differences in I Na,L between WT and cKO myocytes at baseline (Online Figure  VII) . However, consistent with the loss of CaMKII-dependent regulation of I Na,L in the absence of ankyrin-G, we observed a significant difference in isoproterenol-induced I Na,L between WT and cKO myocytes (Online Figure VII) . Specifically, although WT myocytes displayed nearly a 2-fold increase in I Na,L in response to isoproterenol, we observed no statistical change in I Na,L in cKO myocytes±isoproterenol, regardless of the voltage (Online Figure VII; P<0.05 ). Our combined data support an in vivo ankyrin-G-based platform with dual roles for Na v channel recruitment and CaMKIIδ-dependent regulation.
Ankyrin-G cKO Mice Display Bradycardia, Conduction Defects, and Arrhythmia
Impaired Na v 1.5 function is associated with phenotypes of sinus node dysfunction, conduction defects, and ventricular arrhythmia. [1] [2] [3] We, therefore, tested the role of the ankyrin-Gdependent disc platform for cardiac electric regulation. Conscious ankyrin-G cKO mice monitored by ECG telemetry exhibited significant reduction in resting heart rate compared with control mice (Figure 6A-6C ). Impaired atrioventricular (AV) conduction in cKO mice was also readily apparent in cKO mice as noted by an increase in PR interval compared with control mice (Figure 6D-6F ; intra-atrial conduction also reduced as evidenced by increased P wave duration, P<0.05). Moreover, cKO mice displayed a significant increase in the QRS interval, consistent with delayed intraventricular conduction ( Figure 6D, 6E, and 6G ). In summary, in vivo findings strongly support a role of the ankyrin-G-based protein complex in regulation of Na v channel function and cardiac excitability.
Flecainide Induces Bradycardia, QRS Prolongation, and Arrhythmia in cKO Mice
Class 1C anti-arrhythmics (Na v channel antagonists) may be used in clinical practice to identify individuals with Na v channel abnormalities. 29 Moreover, these compounds (eg, flecainide) have been used to uncover Na v channel-based arrhythmia mechanisms in animal models. 30, 31 To test the functional relevance of Na v channel dysfunction in the ankyrin-G cKO mouse, we analyzed ECGs of control and cKO mice after flecainide administration. 32, 33 At baseline, cKO mice displayed bradycardia compared with control mice (Figure 7A , 7B, and 7E). Flecainide reduced heart rate in both control and cKO mice ( Figure 7A-7E) . However, the effect of flecainide on heart rate was significant and potentially pathological in cKO mice as this intervention resulted in an overall ≈30% decrease in heart rate compared with a normal mouse at baseline ( Figure 7E; P<0.05 ). Further, in cKO but not control mice, flecainide caused AV block and ventricular arrhythmia ( Figure 7F-7H) . Specifically, 10% of control mice displayed AV block in response to flecainide, whereas we recorded AV 2.75±0.98 episodes/min; P<0.05). Moreover >80% of cKO mice showed arrhythmia, including bigeminy and nonsustained ventricular arrhythmia, compared with 10% of control mice ( Figure 7H ; P<0.05). Consistent with conscious ECG recordings, anesthetized cKO mice displayed prolonged QRS interval compared with control mice (Online Figure VIII) . This QRS interval difference between genotypes was further accentuated by flecainide administration (Online Figure VIII;  P<0.05) . Ankyrin-G cKO mice also showed increased PR interval duration after flecainide (Online Figure IX; P<0.05) .
Together, these data strongly support the role of ankyrin-Gprotein complex in Na v channel regulation in vivo, as well as link Na v channel-based mechanisms with observed cardiac electric phenotypes in the ankyrin-G cKO mouse.
Ankyrin-G cKO Mice Display Defects in Plakophilin-2 Expression and Cellular Organization
Beyond membrane ion channels, in vitro work supports roles of ankyrin-G for membrane protein regulation at cell junctions. 17, 34 We therefore tested the in vivo requirement of ankyrin-G for expression and localization of key intercalated disc proteins as well as Na v β-subunits that have been previously linked with ankyrin polypeptides. 35 Notably, we observed no difference in expression or localization of disc proteins N-cadherin and β-catenin, or Na v channel β2 and β4 subunits between control and cKO hearts ( Figure 8A-8K ; Online Figure X) . In contrast, plakophilin-2 showed a 50% increase in expression in cKO hearts ( Figure 8A and 8B) . Further, we observed a striking redistribution of plakophilin-2 from the intercalated disc of cKO myocytes to the cytosolic regions of cKO myocytes ( Figure 8K XI). Although prior work proposed a link for ankyrin-G in targeting of connexin43, 17 we observed no difference in con-nexin43 or ZO-1 expression by immunoblot ( Figure 8C and 8D). Together, our new in vivo data clearly support a role of ankyrin-G in intercalated disc protein organization.
Ankyrin-G cKO Mice Display Catecholamine-Induced Arrhythmia and Death
Ankyrin-G cKO mice display several pro-arrhythmic ECG phenotypes associated with reduced I Na (Figures 6 and 7) . However, based on the additional observed molecular defects in ankyrin-G cKO animals (Figure 8 ), we tested cKO animals for arrhythmia susceptibility in response to elevated adrenergic stimulation. Ankyrin-G cKO mice showed arrhythmia phenotypes after a standard intraperitoneal epinephrine injection protocol to mimic catecholaminergic stress (Online Figure XII) . 12 Specifically, the majority (≈62.5%) of cKO mice displayed multiple instances of ventricular arrhythmia, and ≈38% of cKO mice died of malignant arrhythmias after this protocol (Online Figure XII; 3/8 cKO versus 0/6 control; P<0.05). The cKO mice also displayed decreased AV conduction compared with WT mice (increased PR interval; P<0.05; n=5/genotype) in these experiments. Examples of sustained premature ventricular contractions and polymorphic ventricular arrhythmia in cKO mice are shown in Online Figure XIIB and XIIC. We recorded no incidence of ventricular arrhythmia (0%) or death (0%; Online Figure XIIA and XIIE) in WT animals using this protocol. In summary, we conclude that loss of the cardiac ankyrin-G-based protein platform results in proarrhythmic ECG phenotypes at rest and arrhythmia and death in response to catecholaminergic stress. Of note, as catecholamine-based arrhythmias in cKO mice were observed in the absence of elevated CaMKIIδ or I Na,L , we tested for potential alterations in myocyte calcium handling in cKO myocytes. Consistent with whole animal data (eg, premature ventricular contractions), cKO myocytes displayed increased incidence of spontaneous Ca waves compared with WT myocytes (Online Figure XIII; P<0.05 ).
Ankyrin-G cKO Mice Display Cardiac Structural Phenotypes
Ankyrins are linked with assembly and maintenance of structural domains in erythrocytes, epithelia, and neurons. [36] [37] [38] Further, our data, and earlier data from Delmar and colleagues, 17 link ankyrin-G with plakophilin-2, a protein associated with cardiac structural remodeling in humans and mice. 31, 39, 40 We, therefore, examined ankyrin-G hearts for changes in cardiac structure or function at baseline and in aging. At 8 weeks, we observed no difference in heart weight/ body weight (or tibia length) or systolic or diastolic wall thickness between WT and cKO mice (Online Figure XIV) . Although we observed a nonsignificant trend for increased systolic and diastolic LV diameter in cKO mice (p=NS), cKO mice displayed a small, but significant decrease in ejection fraction compared with WT littermates (Online Figure XIV) . Notably, cKO mice displayed obvious cardiac phenotypes with age (≈9 months) as indicated by a further depression in ejection fraction, increase in systolic and diastolic chamber diameters, and reduction of both the anterior and posterior wall thickness compared with WT littermates (Online Figure XV) .
Discussion
Voltage-gated Na v channels are critical for the rapid upstroke of the cardiac action potential and cardiac conduction. Defects in Na v channel function are linked with a host of congenital and acquired forms of human disease, including sinus node dysfunction, atrial fibrillation, conduction disorders, ventricular arrhythmia, and heart failure. [1] [2] [3] Despite these compelling human disease linkages and decades of elegant Na v channel biophysical studies, the field still lacks significant fundamental knowledge of the regulatory mechanisms governing the function of this critical molecule. Here we use in vivo animal models to define the cellular pathway underlying the targeting of Na v 1.5 and its regulatory molecule, CaMKIIδ, to the intercalated disc membrane. Ankyrin-G, a cytoskeletal adapter protein, associates with Na v 1.5 and recruits the channel to the myocyte membrane. Loss of ankyrin-G results in defects in Na v channel expression, localization, and function. We further show that ankyrin-G, via the recruitment of β IV spectrin, also targets CaMKIIδ to the intercalated disc. As CaMKIIδ phosphorylates Na v 1.5 to modulate cardiac myocyte excitability in health and disease, 8, 28 our findings provide data that support the mechanisms underlying the biogenesis of this membrane signaling domain. Finally, our findings confirm in vivo protein pathways for ankyrin-G and Na v 1.5 in heart. Specifically, as described by Delmar and colleagues 17 in cultured myocytes, our in vivo data link ankyrin-G with the desmosomal protein plakophilin-2. Further, our data associate ankyrin-G with the disc protein β IV spectrin. Ankyrin-G cKO mice were surprisingly viable, but display bradycardia, AV conduction defects, QRS prolongation, and arrhythmia associated with flecainide or epinephrine. Consistent with our proposed mechanism of I Na dysfunction in these animals, Na v 1.5 is linked with impulse propagation through the sinoatrial node, 2 the AV node, 41 and the ventricular myocardium. 42 Prior in vivo work links Na v 1.5 dysfunction with bradycardia and reduced sinoatrial node pacemaker potential. 42 Moreover, consistent with our findings, flecainide has been previously shown to evoke ventricular arrhythmias in multiple mouse models of Na v channel deficiency. 30, 31 Although our findings clearly link ankyrin-G with Na v 1.5 targeting, they reveal new ankyrin-G associated pathways that are relevant to cardiac electric, signaling, and structural roles in both health and disease. Genetic mutation in the ankyrinbinding motif of Na v 1.5 has been previously linked with loss of myocyte I Na , abnormal Na v channel targeting, and human Brugada syndrome. 21 However, to date, ankyrin-G (ANK3) variants have not yet been linked with human arrhythmia. Based on past findings in other tissues, as well as work in this study, a pure loss-of-function ANK3 allele may be incompatible with life. Mice simply lacking Ank3 in the cerebellum are frail and display severe neurological defects. Moreover, human ANK3 variants have been linked with bipolar disease, schizophrenia, and autism. [43] [44] [45] Ankyrin-G is required for normal retinal protein trafficking and essential for lateral membrane biogenesis in columnar epithelia. 37, 46 Based on our findings, we predict that more subtle variants may cause sinus node disease, arrhythmia, and even structural heart disease because of defects in intercalated disc infrastructure.
As noted earlier, our data demonstrate that ankyrin-G recruits β IV spectrin to the intercalated disc. In other cell types, β-spectrins, through their association with α-spectrins and actin, form critical submembrane cytoskeletal infrastructure. In fact, defects in spectrins have been linked with a host of pathologies in humans and animals. 26 Moreover, β IV spectrin associates with and targets a subpopulation of CaMKIIδ to the intercalated disc to phosphorylate Na v 1.5. 8, 28 Defects in CaMKIIδ phosphorylation of Na v 1.5 have now been linked with multiple forms of heart failure in humans and animal models. 28, 47 Our in vivo data support a role of ankyrin-G in organization of the intercalated disc. Plakophilin-2 is a key disc protein, linking desmosomal cadherins with desmoplakin and the intermediate filament system. Human plakophilin-2 loss-offunction variants are linked with arrhythmogenic right ventricular cardiomyopathy and Brugada syndrome. 48, 49 Although cardiac phenotypes in the cKO model are distinct from human arrhythmogenic right ventricular cardiomyopathy (increased levels of PKP2 in cKO model versus reduced PKP2 levels in arrhythmogenic right ventricular cardiomyopathy), 39 the unexpected new data on structural defects in ankyrin-G cKO hearts and association with plakophilin-2 alterations are noteworthy. However, the specific relationship between ankyrin-G and plakophilin-2, as well as the potential link between these pathways and the observed structural defects in cKO mice, will require additional investigation. Interestingly, unlike plakophilin-2, we did not observe alterations in expression of intercalated disc proteins N-cadherin, connexin43, ZO-1, or β-catenin in cKO mice by immunoblot. Notably, Delmar and colleagues 50 previously showed reduced connexin43 expression in ankyrin-G siRNA transfected neonatal myocytes.
Although future experiments will be important in defining the relationship between these molecules (ie, compensatory changes versus direct protein partners), our findings clearly Figure 8 . Plakophilin-2 organization is disrupted in cKO myocytes. A-B, Immunoblots of myocyte intercalated disc proteins in wild-type (WT) versus cKO heart. Note that plakophilin-2 levels are significantly increased in cKO hearts (n=4/genotype; P<0.05). C-K, Confocal imaging of WT (left) and cKO (right) myocytes labeled with antibodies for resident intercalated disc proteins. Note that although primarily localized to the disc of WT myocytes, plakophilin-2 is clustered in the perinuclear region of cKO myocytes (arrowheads; Bar=10 μm).
implicate ankyrin-G as a multifunctional regulatory molecule in the heart. Further, our work demonstrates that phenotypes observed in the ankyrin-G cKO mouse likely extend far beyond simple I Na deficiency.
Our in vivo findings demonstrate a critical role for ankyrin-G for intercalated disc Na v 1.5 targeting. However, Na v 1.5 targeting to nonintercalated disc membranes has been proposed as ankyrin-independent, relying instead on unique cellular machinery, including syntrophin/dystrophin, SAP97, caveolin-3, MOG1, and FGF12. 51 Based on the essential role of Na v channels for myocyte excitability, we propose that the vertebrate has evolved multiple mechanisms for Na v 1.5 membrane targeting. Future studies that explore the specific roles of ankyrin-G versus other targeting proteins in ion channel trafficking versus membrane scaffolding will be important to explore the relative contribution of each protein in dictating cardiac excitability and function using in vivo models. Additionally, it will be important to define the identity of populations of Na v 1.5-positive puncta in cKO myocytes (blue arrows in Figure 2F , ie, endosomes, T-tubule populations, etc.). Further, based on the in vivo link between ankyrin-G and plakophilin-2, it will be important to further investigate the mechanistic roles of ankyrin-G in regulation of intermediate filaments at the intercalated disc. Finally, it will be important to investigate the role of ankyrin-G for targeting other Na v channels in heart (eg, brain Na v channel gene products). 
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